Vivo Capital Surplus Fund VIII, L.P.
SEC CIK 1628048 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BOLT | Bolt Biotherapeutics, Inc. | 10% | 1.98M | — | $79.9K | 1 | 2023-11-16 | 2023-11-16 |
Most active insiders at BOLT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Quinn William P. | Pres, CEO, CFO, Dir | $3,045 | $58.4K |
| 2 | Yonehiro Grant | COO | — | $43.8K |
| 3 | Nemec Sarah | Senior VP, Fin, PAO | $2,549 | $26.1K |
Vivo Capital Surplus Fund VIII, L.P. made no open-market trades at BOLT in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-11-20 | 2023-11-16+ | BOLT | Bolt Biotherapeutics, Inc. | Vivo Capital Surplus Fund VIII, L.P. | 10% | S - Sale | $0.9289 | -86.1K | 1.98M | -4% | -$79.9K |
Purchase Sale Sale after option exercise All abbreviations